Florida Depression Treatment Specialists: Compassionate Expert Care
Living with depression in Florida means something different for every person who carries it. For some it is a persistent heaviness that never quite lifts. For others it is a cycle of partial recovery followed by relapse. For a significant number, it is years of trying antidepressants, adjusting doses, switching medications, and still not finding the sustained relief that was promised. If that is where you are, you are not at the end of the road.
Allay Health and Wellness provides specialized depression treatment in Florida from its Palm Beach Gardens clinic, serving patients from across Palm Beach County, Broward County, and South Florida. Our clinical team offers IV ketamine infusion therapy, which is an off-label treatment for depression, as well as Spravato (esketamine), which is FDA-approved for treatment-resistant depression and for depressive symptoms in adults with major depressive disorder with acute suicidal ideation or behavior. Treatment eligibility and outcomes vary by individual, and all care begins with a thorough clinical evaluation.
When Standard Depression Treatment Has Not Been Enough
Most people with depression begin care through a primary care physician, therapist, or psychiatrist who may recommend therapy, lifestyle support, or a first-line antidepressant. For many patients, this approach helps. For others, symptoms continue despite multiple treatment attempts. When a patient has tried two or more antidepressants at appropriate doses and durations without enough improvement, clinicians may describe the condition as treatment-resistant depression.
Treatment-resistant depression is not a personal failure. It simply means standard treatment pathways have not provided sufficient relief for that individual’s clinical needs. In these situations, patients may need a more specialized evaluation to understand what options remain appropriate. At Allay Health and Wellness, specialized depression treatment in Florida is designed for patients who need careful review, medically supervised options, and realistic guidance after conventional care has not been enough.
Depression Treatment Options at Allay Health and Wellness
Our clinical team does not approach depression with a single fixed protocol. The right treatment depends on diagnosis, history, co-occurring conditions, and individual risk factors. The primary depression treatment options available at our Florida clinic are outlined below.
IV Ketamine Infusion Therapy for Depression (Off-Label)
IV ketamine infusion therapy is an off-label treatment for depression. The FDA has not specifically approved IV ketamine therapy for depression or any other mental health condition. That said, off-label prescribing by licensed clinicians is a legal and standard medical practice, and the body of published research examining ketamine for treatment-resistant depression continues to grow.
Ketamine works on the brain’s glutamate system, specifically through NMDA receptor modulation. This mechanism is distinct from conventional antidepressants that primarily target serotonin, norepinephrine, or dopamine. By influencing glutamate pathways, ketamine may support neuroplasticity processes that are relevant to mood regulation. Some research suggests that patients may notice changes in depressive symptoms more quickly than with standard antidepressants, though individual responses vary significantly and no specific outcome is guaranteed.
At Allay Health and Wellness, IV ketamine is administered slowly through an intravenous line in a private, monitored clinical room. A licensed clinician is present throughout every session, and vital signs are tracked continuously. A standard initial course typically involves six infusions over two to three weeks, with maintenance sessions scheduled based on clinical response.
Spravato (Esketamine) for Treatment-Resistant Depression: FDA-Approved
Spravato (esketamine) is an FDA-approved nasal spray indicated for two specific conditions only:
- Treatment-resistant depression (TRD) in adults, used alongside an oral antidepressant
- Depressive symptoms in adults with major depressive disorder (MDD) with acute suicidal ideation or behavior
These are the only two FDA-approved indications for Spravato. It is not approved for anxiety, PTSD, chronic pain, or any other condition. A responsible clinician will never recommend Spravato for uses outside these two indications, and no claims to the contrary are made at Allay Health and Wellness.
Spravato is administered as a self-applied nasal spray in a certified clinical setting under the FDA’s Risk Evaluation and Mitigation Strategy (REMS) program. It is never dispensed for home use. Each session includes a minimum two-hour monitored observation period during which blood pressure, heart rate, and overall response are tracked. A licensed clinician is present throughout.
Because of its FDA-approved status, Spravato may be eligible for insurance coverage through Medicare and major private insurers when medical necessity criteria are met, which is a meaningful practical difference from off-label IV ketamine.
Ketamine-Assisted Therapy
For patients whose depression is intertwined with trauma, chronic stress, grief, or complex psychosocial history, the infusion itself may be most effective when paired with structured clinical support before and after sessions. Our ketamine-assisted therapy in Florida program combines supervised IV ketamine infusions with preparation and integration work designed to help patients make meaningful use of the experience.
Depression and Co-Occurring Conditions
Depression rarely appears in isolation. Many patients seeking depression treatment in Florida are also managing anxiety, PTSD, chronic pain, substance use history, or other mental health concerns. These overlapping conditions can affect symptoms, treatment planning, medication decisions, and overall safety considerations. At Allay Health and Wellness, each patient receives a careful evaluation so the care plan reflects the full clinical picture rather than depression alone.
For patients whose depression occurs alongside anxiety, services such as ketamine therapy for anxiety may provide a helpful clinical context. Patients with trauma-related symptoms may need evaluation through PTSD treatment or care that considers the PTSD brain healing process. When depression is connected with ongoing pain, ketamine for chronic pain may be discussed as part of a broader treatment conversation.
Depression connected to addiction or substance use also requires careful review. Allay Health and Wellness evaluates substance use history before recommending ketamine-based care because safety and appropriateness matter. For many patients, effective depression treatment in Florida depends on addressing these related conditions together, not separately.
Who May Be a Candidate for Specialized Depression Treatment in Florida
Before specialized depression care is recommended, patients need a full clinical evaluation by a licensed provider. This review helps determine diagnosis, treatment history, current medications, safety risks, and whether IV ketamine or Spravato may be appropriate. Candidacy for off-label IV ketamine or Spravato generally takes into account the following:
- Diagnosis: A formal diagnosis of major depressive disorder, bipolar depression, or treatment-resistant depression from a licensed clinician.
- Prior treatment history: A documented record of trying and not responding adequately to at least two antidepressant medications or other standard treatments. For Spravato, this is part of the FDA-approved eligibility requirement.
- Current medications: Your clinician will review your existing regimen for potential interactions and to confirm whether concurrent oral antidepressant use is appropriate (required for Spravato per FDA indication).
- Medical and psychiatric history: Certain cardiovascular conditions, active uncontrolled psychosis, pregnancy, and other factors may affect candidacy or require additional evaluation.
- Substance use history: Patients with a history of substance use disorders are evaluated carefully because ketamine is a Schedule III controlled substance. This does not automatically disqualify someone, but it is a significant factor in the clinical assessment.
Not every patient who presents for depression treatment will be an appropriate candidate for these therapies, and our team does not recommend treatment when the clinical picture does not support it.
Risks and Side Effects: What Patients Must Know Before Starting
Every patient at Allay Health and Wellness receives a full disclosure of known risks before treatment begins. Depression treatment in Florida using ketamine or esketamine carries the following documented side effects:
- Dissociation: A temporary altered state involving changes in how you perceive time, space, or self. This is a well-documented and expected effect of ketamine at therapeutic doses. It is monitored by clinical staff throughout every session and typically resolves before discharge.
- Sedation: Ketamine produces sedation. Patients may not drive on the day of any infusion or Spravato session. A responsible adult must arrange transportation home.
- Blood pressure changes: Temporary increases in blood pressure are common during both ketamine infusions and Spravato sessions. Vital signs are checked before, during, and after every session.
- Nausea and dizziness: Generally mild and typically resolving within the post-session observation period.
- Psychological effects during sessions: Some patients experience anxiety, heightened emotional intensity, or unusual perceptions. Clinical staff are present throughout every session and are trained to provide support.
- Controlled substance considerations: Ketamine is a Schedule III controlled substance under federal law. Dependency risk at supervised therapeutic doses is considered low, but it is not zero.
For Spravato specifically, the FDA REMS program mandates that each session be administered only in a certified healthcare setting, that patients be observed for a minimum of two hours post-dose, and that the medication never be given to the patient for self-administration at home. Individual risk profiles vary. All patients undergo a thorough risk assessment at intake before treatment begins.
Insurance and Cost Considerations for Depression Treatment in Florida
Insurance coverage for depression treatment in Florida depends on the treatment type, diagnosis, medical necessity, and the patient’s specific insurance plan. Off-label IV ketamine infusion therapy for depression is generally not covered by most insurance plans because coverage usually applies to FDA-approved uses of a treatment. At Allay Health and Wellness, our team verifies available benefits before treatment begins and provides a clear cost summary so patients understand expected financial responsibility before making decisions.
Spravato may follow a different insurance pathway because it is FDA-approved for treatment-resistant depression when used with an oral antidepressant and for depressive symptoms in adults with MDD with acute suicidal ideation or behavior. Medicare Part B, Cigna, United Healthcare, and Aetna may consider coverage when documentation and medical necessity criteria are met. Our team helps with eligibility verification, prior authorization, documentation, and appeals when appropriate. Coverage is never guaranteed and depends on individual plan terms, diagnosis, and documentation. Our team will give you an accurate picture of your expected costs before your first session.
Depression Treatment Locations Across Florida
Patients searching for depression treatment in Florida often need more than a nearby appointment. They need a clinic that offers careful evaluation, medically supervised treatment options, and clear guidance about what may or may not be appropriate. Allay Health and Wellness operates from 11000 Prosperity Farms Rd, Suite 101, Palm Beach Gardens, FL 33410, serving patients across South Florida, including West Palm Beach, Jupiter, North Palm Beach, Riviera Beach, Royal Palm Beach, Lake Park, Palm Springs, Juno Beach, Delray Beach, and Deerfield Beach.
Our clinic provides IV ketamine infusions and insurance-covered Spravato for qualifying depression-related cases, along with care for PTSD, anxiety, chronic pain, and broader mental health concerns. Patients from nearby communities may come to Allay Health and Wellness for evaluation, treatment planning, insurance questions, and follow-up support. The clinic also offers resources related to ketamine therapy, Spravato, PTSD, depression, chronic pain, and mental wellness.
For patients comparing options for depression treatment in Florida, local access matters, but clinical standards matter more. Allay Health and Wellness begins with an individualized evaluation before making treatment recommendations.
Why Patients Across Florida Choose Allay Health and Wellness
Patients considering depression treatment in Florida often look for a clinic that communicates honestly, evaluates carefully, and avoids unrealistic promises. Allay Health and Wellness has served South Florida for more than eight years, working with patients who may not have found sufficient relief through conventional depression treatments. We do not guarantee outcomes, and we do not begin treatment without first completing a clinical review to determine whether a specific option may be appropriate.
Our team includes Katy Redfield, APRN, Co-Founder and Program Director, with more than 20 years of nursing experience; Nicholas Marino, MBA, Co-Founder and CEO, with more than 13 years in mental health practice management; Roland Verfaillie, Ph.D., Clinical Director and licensed mental health therapist, with more than 30 years of experience; and Daniel Cartledge, M.D., consultant and double board-certified in pain management and physical medicine and rehabilitation.
We are also a trusted ketamine clinic in Florida with a track record in the community that reflects the standard of care we hold ourselves to. Our approach to depression treatment in Florida is grounded in patient safety, informed consent, clinical monitoring, and individualized planning. Patients who want to understand their options can expect clear explanations, careful screening, and treatment recommendations based on their diagnosis, history, and medical needs.
FAQs about Depression Treatment in Florida
Q1. Is IV ketamine FDA-approved for depression treatment in Florida?
No. IV ketamine for depression is off-label. Spravato is FDA-approved for specific depression-related indications. A licensed clinician determines whether either option may be appropriate.
Q2. What is the difference between IV ketamine and Spravato?
IV ketamine is given by infusion and used off-label. Spravato is an FDA-approved nasal spray for specific depression indications. They differ in approval, delivery, and coverage.
Q3. How many treatment sessions are usually needed?
IV ketamine often begins with six infusions over two to three weeks. Spravato usually starts twice weekly for four weeks. Individual schedules depend on evaluation and response.
Q4. Can I continue taking my current antidepressants during treatment?
Your clinician will review your medications before treatment. Some patients continue antidepressants. For Spravato, an oral antidepressant is part of the FDA-approved treatment-resistant depression indication.
Q5. Will insurance cover depression treatment at your Florida clinic?
Off-label IV ketamine is usually not covered by insurance. Spravato may be covered for qualifying patients when medical necessity criteria are met. Benefits are verified before treatment.
Q6. Do I need a referral to schedule a consultation?
No referral is required. Patients should bring their diagnosis records, prior treatment history, and current medication details. Collaboration with existing healthcare providers is supported when appropriate.
Q7. Is ketamine treatment appropriate for patients with a history of substance use?
A substance use history requires careful clinical review. It does not automatically disqualify a patient, but safety, stability, and medical history must be evaluated first.
Schedule Your Consultation for Depression Treatment in Florida
If standard antidepressants and conventional therapy have not provided the relief you need, and you want to speak with a clinical team that will evaluate your situation honestly and thoroughly, Allay Health and Wellness is ready to help.
Allay Health and Wellness
11000 Prosperity Farms Rd, Suite 101
Palm Beach Gardens, FL 33410
Phone: (561) 421-6444
Email: [email protected]
Contact us to request a free consultation. Our team will verify your insurance benefits, answer your clinical questions, and schedule your evaluation at a time that works for you. We serve patients from West Palm Beach, Jupiter, North Palm Beach, Riviera Beach, Royal Palm Beach, Lake Park, Palm Springs, Juno Beach, Boca Raton, Delray Beach, Deerfield Beach, and communities across Palm Beach and Broward Counties.
Medical Disclaimer: The information on this page is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. IV ketamine infusion therapy for depression is an off-label use of ketamine and has not been specifically approved by the FDA for this condition. Spravato (esketamine) is FDA-approved for treatment-resistant depression (used with an oral antidepressant) and for depressive symptoms in adults with major depressive disorder with acute suicidal ideation or behavior only. It is not approved for PTSD, chronic pain, anxiety, or any other condition. Individual treatment outcomes vary and are not guaranteed. All treatments at Allay Health and Wellness are provided only after evaluation and approval by a licensed clinician. Ketamine is a Schedule III controlled substance administered exclusively under medical supervision in a licensed clinical setting. Spravato is available only through certified healthcare settings under the FDA REMS program. Viewing this page does not establish a provider-patient relationship.
Reviewed by Nicholas Marino, MBA, Co-Founder and CEO, Allay Health and Wellness
